Inventor · Saint-Leu-la-Forêt, FR

Jean-Daniel Brion

19Patents
3h-index
57Co-inventors
63Inventor score

Filing activity: Apr 11, 1989 → Apr 6, 2023

Most-cited inventions

PatentTitleAreaCited byStatus
US6350757B1 Beta-carboline compounds Human Necessities 24 Expired
US5391569A New chromene compounds having a triene side chain Chemistry; Metallurgy 10 Expired
US4975455A New heteroarotinoid compounds Human Necessities 7 Expired
US11376245B2 Dizocilpine derivatives as peripheral NMDA receptor antagonists Chemistry; Metallurgy 2 Active
US5550143A Heterocyclic compounds Chemistry; Metallurgy 1 Expired
US8273768B2 Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization Chemistry; Metallurgy 1 Active
US4975454A Triene compounds having a chromene structure Human Necessities 1 Expired
US5654323A Heterocyclic compounds Chemistry; Metallurgy 1 Expired
US12274694B2 Dizocilpine derivatives as peripheral NMDA receptor antagonists Chemistry; Metallurgy 0 Active
US5409952A Heterocyclic compounds: 2-styryl-4H-1-benzopyran-4-ones Chemistry; Metallurgy 0 Expired
US5622957A Benzopyrrolizinoquinolizinones Human Necessities 0 Expired
US5602131A EburnanE analogues Human Necessities 0 Expired
US11014871B2 “Multi-target” compounds with inhibitory activity towards histone deacetylases and tubulin polymerisation, for use in the treatment of cancer Chemistry; Metallurgy 0 Active
US10653694B2 Cytotoxic compounds which are inhibitors of the polymerisation of tubulin Chemistry; Metallurgy 0 Active
US10538482B2 Adamantane and memantine derivatives as peripheral NMDA receptor antagonists Chemistry; Metallurgy 0 Active
US5597819A Phenothiazine cytokine inhibitors Chemistry; Metallurgy 0 Expired
US7339061B2 3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same Chemistry; Metallurgy 0 Expired
US11944616B2 Dizocilpine derivatives as peripheral NMDA receptor antagonists Chemistry; Metallurgy 0 Active
US11247982B2 NMDA receptor modulators, compositions comprising same and use of these compounds in the treatment of diseases involving the central nervous system Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.